within Pharmacolibrary.Drugs.ATC.M;

model M05BA02
  extends Pharmacokinetic.Models.PK_2C(
    weight         = 70,
    F              = 1,
    Cl             = 1.9999999999999998e-05,
    adminDuration  = 600,
    adminMass      = 1500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.02,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,            
    Vdp             = 0.04,
    k12             = 1.4,
    k21             = 1.4
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M05BA02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Clodronic acid (clodronate) is a first-generation, non-nitrogen-containing bisphosphonate used to treat hypercalcemia of malignancy and to prevent skeletal complications in patients with metastatic bone disease. It is also used for the treatment of osteoporosis and Paget's disease of bone. Although approved in many countries, it is not approved for use in the United States.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects and cancer patients; intravenous administration.</p><h4>References</h4><ol><li><p>Frediani, B, et al., &amp; Cremonesi, G (2009). Clodronic acid formulations available in Europe and their use in osteoporosis: a review. <i>Clinical drug investigation</i> 29(6) 359–379. DOI:<a href=&quot;https://doi.org/10.2165/00044011-200929060-00001&quot;>10.2165/00044011-200929060-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19432497/&quot;>https://pubmed.ncbi.nlm.nih.gov/19432497</a></p></li><li><p>Licata, AA (1997). Bisphosphonate therapy. <i>The American journal of the medical sciences</i> 313(1) 17–22. DOI:<a href=&quot;https://doi.org/10.1097/00000441-199701000-00004&quot;>10.1097/00000441-199701000-00004</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9001162/&quot;>https://pubmed.ncbi.nlm.nih.gov/9001162</a></p></li><li><p>Hurst, M, &amp; Noble, S (1999). Clodronate: a review of its use in breast cancer. <i>Drugs &amp; aging</i> 15(2) 143–167. DOI:<a href=&quot;https://doi.org/10.2165/00002512-199915020-00007&quot;>10.2165/00002512-199915020-00007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10495073/&quot;>https://pubmed.ncbi.nlm.nih.gov/10495073</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M05BA02;
